Clinical and Biochemical Function of Polymorphic NR0B1 GGAA-microsatellites in Ewing Sarcoma: a Report from the Children's Oncology Group
Overview
Authors
Affiliations
Background: The genetics involved in Ewing sarcoma susceptibility and prognosis are poorly understood. EWS/FLI and related EWS/ETS chimeras upregulate numerous gene targets via promoter-based GGAA-microsatellite response elements. These microsatellites are highly polymorphic in humans, and preliminary evidence suggests EWS/FLI-mediated gene expression is highly dependent on the number of GGAA motifs within the microsatellite.
Objectives: Here we sought to examine the polymorphic spectrum of a GGAA-microsatellite within the NR0B1 promoter (a critical EWS/FLI target) in primary Ewing sarcoma tumors, and characterize how this polymorphism influences gene expression and clinical outcomes.
Results: A complex, bimodal pattern of EWS/FLI-mediated gene expression was observed across a wide range of GGAA motifs, with maximal expression observed in constructs containing 20-26 GGAA motifs. Relative to white European and African controls, the NR0B1 GGAA-microsatellite in tumor cells demonstrated a strong bias for haplotypes containing 21-25 GGAA motifs suggesting a relationship between microsatellite function and disease susceptibility. This selection bias was not a product of microsatellite instability in tumor samples, nor was there a correlation between NR0B1 GGAA-microsatellite polymorphisms and survival outcomes.
Conclusions: These data suggest that GGAA-microsatellite polymorphisms observed in human populations modulate EWS/FLI-mediated gene expression and may influence disease susceptibility in Ewing sarcoma.
Yasir M, Park J, Chun W Int J Mol Sci. 2023; 24(20).
PMID: 37894854 PMC: 10607184. DOI: 10.3390/ijms242015173.
Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.
Gong H, Xue B, Ru J, Pei G, Li Y Cancers (Basel). 2023; 15(16).
PMID: 37627063 PMC: 10452796. DOI: 10.3390/cancers15164035.
Molnar C, Reina J, Herrero A, Heinen J, Mendiz V, Bonnal S PNAS Nexus. 2023; 1(4):pgac222.
PMID: 36714878 PMC: 9802468. DOI: 10.1093/pnasnexus/pgac222.
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation.
Gao Y, He X, Wu X, Huang Y, Toneyan S, Ha T Nat Cell Biol. 2023; 25(2):298-308.
PMID: 36658219 PMC: 10101761. DOI: 10.1038/s41556-022-01060-1.
Orth M, Surdez D, Faehling T, Ehlers A, Marchetto A, Grossetete S Cell Rep. 2022; 41(10):111761.
PMID: 36476851 PMC: 10333306. DOI: 10.1016/j.celrep.2022.111761.